• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• E
• Edwina, Angela Elma
  Katholieke Universiteit Leuven
• PI-046 - COMPARISON OF A COLORIMETRIC ASSAY AND ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY FOR QUANTIFYING PARACETAMOL PLASMA CONCENTRATIONS: DESIGN OF A GERIATRIC PHARMACOKINETICS STUDY.
  Angela Elma Edwina
  Favorite
• El Rouby, Nihal
  University of Cincinnati
• PI-031 - PILOT, FEASIBILITY TESTING OF DPYD AND UGT1A1 PRIOR TO CHEMOTHERAPY IN A COMMUNITY-BASED CANCER CENTER.

  
  Nihal El Rouby
  Favorite
• PII-046 - GENOME WIDE ASSOCIATION STUDY (GWAS) OF SECOND-GENERATION ANTIPSYCHOTICS (SGA)-INDUCED METABOLIC SYNDROME (METS) IN BIOME BIOBANK.
  Nihal El Rouby
  Favorite
• PWIII-001 - PILOT, FEASIBILITY TESTING OF DPYD AND UGT1A1 PRIOR TO CHEMOTHERAPY IN A COMMUNITY-BASED CANCER CENTER.

  
  Nihal El Rouby
  Favorite
• El-Zailik, Asma
  Vir Biotechnology
• LB-009 - IMPACT OF INTRAMUSCULAR INJECTION SITE ON SOTROVIMAB PHARMACOKINETICS.
  Asma El-Zailik
  Favorite
• Emery, Maurice
  Esperion Therapeutics, Inc.
• PI-044 - CLINICAL DRUG–DRUG INTERACTION STUDIES TO EVALUATE THE EFFECTS OF BEMPEDOIC ACID, A SMALL-MOLECULE INHIBITOR OF ATP CITRATE LYASE, ON THE PHARMACOKINETICS OF CONCOMITANT STATIN THERAPIES.
  Maurice Emery
  Favorite
• Enogieru, Osatohanmwen
  Amgen
• EP-030 - PRECLINICAL IN-VITRO ASSAYS EVALUATING PROTEIN DEGRADERS (PDS) ASSOCIATE WITH ORAL BIOAVAILABILITY AND VOLUME OF DISTRIBUTION IN TISSUES.

  
  Osatohanmwen Enogieru
  Favorite